awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37486753-232FD19D-8BDD-4DA0-9C25-09F7C12E2D4D
Q37486753-232FD19D-8BDD-4DA0-9C25-09F7C12E2D4D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37486753-232FD19D-8BDD-4DA0-9C25-09F7C12E2D4D
Current status of cediranib: the rapid development of a novel anti-angiogenic therapy.
P2860
Q37486753-232FD19D-8BDD-4DA0-9C25-09F7C12E2D4D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37486753-232FD19D-8BDD-4DA0-9C25-09F7C12E2D4D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e3838e232590a0a64f0c9224564847d5919d3be2
P2860
Phase I and pharmacokinetic study of daily oral AZD2171, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer: the National Cancer In